|
Daily Medical Update
Complications of transfusions
Sunday, April 05, 2026
|
🔬 Practice‑Changing Findings
Evidence from RCTs and meta‑analyses published in the last 12 months.
|
Transfusion Clinique et Biologique (2025) - Systematic Review and Meta-analysis
Key Findings
- Platelet antibody screening lowered post-transfusion platelet refractoriness from 28.6% to 15.4%, a 46% relative risk reduction.
- Patients identified by screening and then given compatible platelets had lower mortality, better engraftment, and fewer transfusion-related complications.
📋 Practice Implication: High-risk hematology and allo-HSCT transfusion pathways should incorporate anti-HLA antibody screening and access to compatible platelet products.
|
Annals of Hematology (2026) - Systematic Review and Meta-analysis
Key Findings
- Liberal transfusion thresholds improved short-term quality of life versus restrictive thresholds, with a pooled Hedges g of 0.54.
- Liberal strategies required about 4 additional RBC units per patient and increased ferritin by 868 ug/L, with no clear difference in mortality or transfusion reactions.
📋 Practice Implication: In lower-risk MDS, reserve liberal transfusion thresholds for symptomatic patients after weighing short-term quality-of-life gains against iron overload and cumulative exposure.
|
Journal of Critical Care (2025) - Meta-analysis of Randomized Clinical Trials
Key Findings
- Restrictive thresholds reduced red blood cell exposure by about 2.2 units per patient compared with liberal strategies.
- Mortality, unfavorable neurologic outcome, ARDS, infection, thromboembolism, and length of stay were not significantly different between strategies.
📋 Practice Implication: For acute brain injury, a restrictive hemoglobin trigger is a reasonable default when the goal is to limit transfusion exposure without worsening major outcomes.
|
Medicine (2026) - Systematic Review and Meta-analysis
Key Findings
- Protamine during TAVI reduced blood transfusion need (OR 0.70), major bleeding (OR 0.54), and life-threatening bleeding (OR 0.33).
- Major vascular complications also fell (OR 0.44), with no significant increase in acute kidney injury, stroke, myocardial infarction, or 30-day mortality.
📋 Practice Implication: Unless contraindicated, protamine reversal should be part of TAVI hemostasis protocols to reduce bleeding-driven transfusion complications and vascular events.
|
The Journal of Surgical Research (2026) - Systematic Review and Meta-analysis
Key Findings
- Perioperative blood transfusion increased anastomotic thrombosis risk (RR 1.71) and increased flap failure risk (RR 2.02) after free flap reconstruction.
- The association increased most in breast reconstruction, where flap failure risk reached RR 7.96 and anastomotic thrombosis risk reached RR 2.94.
📋 Practice Implication: Microsurgical reconstruction teams should treat transfusion exposure as a modifiable flap-risk factor and intensify blood-conservation measures before defaulting to perioperative transfusion.
|
|
Recent evidence on complications of transfusion emphasizes reducing avoidable exposure and improving product selection rather than defaulting to broader transfusion use. Across hematology, neurocritical care, TAVI, and microsurgery, targeted screening or restrictive strategies lowered platelet refractoriness, transfusion burden, bleeding, vascular events, and flap thrombosis without a clear penalty in mortality or other major outcomes. Liberal transfusion can improve short-term quality of life in selected patients with myelodysplastic syndromes, but this benefit comes with higher cumulative exposure and iron-loading risk.
|
|